High Inflation Puts...
Health Care: Drugs
Progenics Pharmaceuticals Inc. (PGNX: NASDAQ)
$9.87 -0.30 | -2.95%
02/09/12 - 12:21 PM ET
62.35K / 204.40K
Vol / Avg. Vol:10.17 / 10.17
Open / Prev. Close:9.74 - 10.17
Today's Range:4.50 - 10.50
52 Wk Range:19.09%
Performance YTD:TheStreet Rating:
Portfolios with PGNX
- Portfolio NameUser Type
- ContributorStocks At New 52-Week Highs...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks At New 52-Week Highs...
- ContributorStocks Under-$10 Moving Hig...
- ProTudor Investment
- ContributorBarron's Insider Purchases ...
- UserRob's 2007 Holdings
- Usergrtdane Portfolio 1
- UserS-0009
- UserAmy Dala 85 portfolio 2
Latest PGNX Headlines from TheStreet
- 7 Stocks Hitting New 52-Week Highs 12.21.11 | 01:12 pm
- Progenics Stock Soars (PGNX) 12.20.11 | 08:12 am
- Progenics Stock Soars (PGNX) 11.30.11 | 04:11 pm
- 7 Stocks Under $10 Moving Higher 11.30.11 | 12:11 pm
- Progenics Pharmaceuticals Inc. Stock Upgraded (PGNX) 08.29.11 | 08:08 am
- Stocks Under $5: New Biotech Find
12.12.10 | 03:12 pm - Stocks Under $5: New Biotech Find 12.09.10 | 10:12 am
- Stocks Under $5: New Biotech Find 12.09.10 | 06:12 am
- Biotech Stock Mailbag: Oncothyreon 10.16.09 | 07:10 am
- Early Movers: Pump Up the Volume 10.14.09 | 08:10 am
Press Releases for PGNX
- Salix And Progenics Announce Positive Highly Statistically Significant Results Of Oral Methylnaltrexone For Phase 3 Trial In Chronic, Non-Cancer Pain Subjects With Opioid-Induced Constipation - Business Wire 12.20.11 | 07:12 am
- Progenics And Salix Announce FDA Acceptance Of SNDA Filing For RELISTOR® In Patients With Non-Cancer Pain - Business Wire 08.30.11 | 07:08 am
- Progenics Pharmaceuticals To Webcast Upcoming Presentations - Business Wire 04.04.11 | 08:04 am
- Progenics Pharmaceuticals Announces Fourth Quarter And Year-End 2010 Financial Results - Business Wire 03.15.11 | 08:03 am
- Progenics Pharmaceuticals Announces Changes In Executive Responsibilities - Business Wire 03.09.11 | 07:03 am
- Progenics Reports Positive Preliminary Data From Ongoing Phase 1 Clinical Study Of PSMA ADC - Business Wire 02.17.11 | 04:02 pm
- Salix Pharmaceuticals And Progenics Pharmaceuticals Announce Worldwide License Agreement For RELISTOR® - Business Wire 02.07.11 | 07:02 am
- Progenics Pharmaceuticals And Salix Pharmaceuticals Announce Worldwide License Agreement For RELISTOR® - Business Wire 02.07.11 | 07:02 am
- Pfizer Inc And Progenics Alert Physicians And Patients To Information Related To Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging - Business Wire 01.25.11 | 02:01 pm
- Progenics Pharmaceuticals Announces Phase 2 Clinical Trial Of Subcutaneous Methylnaltrexone In Japan By Ono Pharmaceutical - Business Wire 11.16.10 | 08:11 am
Partner Headlines for PGNX
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
- 5 Stocks Posting Big Jumps On Tuesday - Seeking Alpha 12.21.11 | 07:12 am
- Morning Market Movers - Benzinga 12.20.11 | 09:12 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Paul Tudor Jones' Favorite Long Positions - Seeking Alpha 03.25.11 | 08:03 am
- Progenics Reports Positive Preliminary Data from Ongoing Phase 1 Clinical Study of PSMA ADC - Benzinga 02.17.11 | 04:02 pm
- UPDATE 1-Progenics licenses constipation shot to Salix Pharma - Reuters 02.07.11 | 08:02 am
- Drug Development Spotlight: The mTOR's New Clothes? - Seeking Alpha 11.23.10 | 09:11 am
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
